Myasthenia gravis trials in Switzerland

3 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis

  Where

  Sankt Gallen

  Age

  18 years to 74 years

  People

  115 worldwide

  Run by

  Janssen Research & Development, LLC

  See details and how to joinNCT07217587 · EU 2025-521130-28-00
• Phase 3Taking people
  Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)

  Where

  Bern

  Age

  18 years and over

  People

  264 worldwide

  Run by

  Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

  See details and how to joinNCT06463587 · EU 2023-507746-83-00
• Phase 2/3Taking people
  A Study of Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of Age With Generalized Myasthenia Gravis

  Where

  Lausanne

  Age

  2 years to 17 years

  People

  12 worldwide

  Run by

  argenx

  See details and how to joinNCT06392386 · EU 2023-506159-12-00